[FRENCH CYSTIC FIBROSIS EPIDEMIOLOGY AFTER A DECADE OF NEONATAL SCREENING]

Related Experiment Video

Updated: Mar 27, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

683

Isabelle Durieu

    La Revue Du Praticien
    |January 12, 2016
    PubMed

    Insights

    Cystic fibrosis life expectancy has dramatically increased due to specialized care and early screening. Despite improvements, chronic respiratory issues remain a key challenge for patients.

    Area of Science:

    • Pulmonology and Genetics
    • Pediatrics and Public Health

    Context:

    • Cystic fibrosis (CF) survival has significantly improved since 1938, extending to nearly 50 years in Western nations.
    • Improvements are attributed to advanced symptomatic treatments and specialized multidisciplinary care teams.
    • The increasing prevalence of adult CF patients highlights the need for long-term management strategies.

    Purpose:

    • To review the advancements in cystic fibrosis care and their impact on patient outcomes.
    • To emphasize the critical role of early diagnosis through neonatal screening.
    • To discuss the persistent challenges, particularly chronic respiratory insufficiency, and the role of lung transplantation.

    Summary:

    • Life expectancy for cystic fibrosis patients has risen substantially, largely due to improved nutritional and respiratory care.
    • Systematic neonatal screening prevents diagnostic delays, enabling early and optimal management with demonstrated nutritional benefits.
    • Adult CF patients now outnumber children, yet the median age of death remains under thirty, closely tied to respiratory insufficiency.

    Impact:

    • Enhanced survival rates and quality of life for individuals with cystic fibrosis.
    • Neonatal screening facilitates timely intervention, significantly improving long-term prognosis.
    • Lung transplantation is a critical intervention for approximately 100 patients annually facing end-stage respiratory failure.

    More Related Videos

    Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

    Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

    Published on: April 19, 2024

    1.3K
    Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD09:47

    Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

    Published on: September 13, 2018

    17.5K

    Related Concept Videos

    Cystic Fibrosis: Pathogenesis01:23

    Cystic Fibrosis: Pathogenesis

    Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
    CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
    1.0K
    Cystic Fibrosis: Management01:24

    Cystic Fibrosis: Management

    Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
    Sinus disease and chronic...
    619
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    330